As one of the biggest country in the world,
based on area and number of inhabitant, Indonesia has many problems to
solve. Since in the future I’ll be a pharmacist, I concern in medical world’s
problem of Indonesia .
Drugs is an important part of a medication, and there is a report said that
drug’s cost is about 40-80% of all medication cost. But, there is a limitation
for people to access suitable drugs cause of the high price of them. This
issues has shared and discussed in many forum. Until now, still, the drug which
can be easily accessed is for common illness like cough, influenza, etc.
Whereas, people who suffer some other widely spread illness like cancer and
tuberculosis, still indisposed for taking the drug because of the high costs.
However, what kind of illness, whether it’s light or heavy disease, the
patients have to able to accessed the suitable drugs.
This
issue is like a chain which seems like never end. Lack of drug’s research based
in Indonesia ,
unavailability of raw material, promotion cost, rivalry between pharmaceutical
industry, and lack of information about drugs for common people are the main
causes of the high drug’s cost. To solve those all, we need support and
contribution from all parts, pharmacist, doctor, industry, also common people.
In addressing this issue, I would like to render my opinion. I’m interested in
two aspects, role of BPOM in regulating the drug’s distribution and research based in Indonesia . BPOM
is the center of drug distribution regulator, so the role of BPOM in delimit
the number and price of drug is really important. We need firmness from BPOM to
discipline the number and price of drugs which are revolved in people. BPOM can
cooperate with universities to do that together. Formation of committee in
university which has pharmacy faculty to help BPOM control drug is a way to
always monitoring availability of drug and people take medicine correctly.
Beside
always monitoring the distribution and price of drug, we need to look at upper
case, lack of drug research in Indonesia
makes us always import drug’s raw material. Whereas, in fact Indonesia is rich
of drug material. As the country with 2nd largest biodiversity in the world, Indonesia has
big nature wealth. Since the budget allocated for research in Indonesia hasn’t been satisfy enough now, about
<0,1% from total Indonesia ’s
APBN, efficiency is the best solution. The relation between pharmaceutical
industry and researcher hasn’t connected well. There are many researches which
aren’t useful for people because there aren’t action to process the research
become product which can be used directly by people. Existence an organization
which can connect pharmaceutical industry and researcher will make effort in a
certain direction, what is needed to be researched by reseacher and what
research has been done and can be processed more. This organization have to
gather information from both side, industry and research, also can give
guideline to both of them the requirement of people now. I’m sure the increase
of efficient researches and active role from BPOM will help people to get more
economic drugs.
as I describe before, this issue is big problem in Indonesia. My thoughts are still 'normative' and it's an honor for me to hear your ideas and comments :)
yeah grammar acakadut, sekali2 lah haha *kesambet*
0 comment:
Posting Komentar
speak up! ;)